Curis | CRIS - Ebit

Stock Price
0.59
Daily Change
0.02 3.84%
Monthly
7.67%
Yearly
-71.26%
Q2 Forecast
0.58

Curis reported $-7.88M in EBIT for its fiscal quarter ending in December of 2025.





Ebit Change Date
Alaunos Therapeutics USD -1.19M 148K Sep/2025
Amgen USD 3.83B 130M Mar/2026
AstraZeneca USD 7.11B 4.14B Mar/2026
Bayer EUR 1.11B 1.51B Dec/2025
Bristol-Myers Squibb USD 3.56B 90M Mar/2026
CSL USD 2.64B 116M Dec/2025
Curis USD -7.88M 4.31M Dec/2025
Eli Lilly USD 9.78B 792M Mar/2026
Exelixis USD 251.34M 15.43M Mar/2026
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 2.29B 856M Mar/2026
Incyte USD 344.17M 39.71M Mar/2026
Merck USD -1.88B 8.12B Mar/2026
Novartis USD 4.18B 118M Mar/2026
Pfizer USD 4.99B 340M Mar/2026
Roche Holding CHF 9.56B 2.1B Dec/2025
Sanofi EUR 1.94B 239M Mar/2026
Takeda JPY 257.49B 568.56B Dec/2025
TG Therapeutics USD 50.49M 21.13M Dec/2025
Verastem USD -41.48M 4.44M Dec/2025
Xoma USD -10.08M 4.4M Jun/2024